The question as to whether human leukemia is to be classified as a neoplasm or as an atypical hyperplastic response of the hemopoietic tissues to an unknown agent has been the subject of much speculation. The lymphosarcomata have been classified with the leukemias by many investigators because of the obvious similarity certain cases of leukemia bear to true neoplasms. The atypical cells of leukemia usually show an extremely generalized distribution, whereas the lymphosarcomatous cells exhibit local infiltrative growth with more or less discrete foci of metastasis. Thus, leukemia has been considered by many to be a "systemic disease" (hyperplastic or neoplastic) with multicentric foci of origin, whereas the sarcomata are said to be neoplasms of unicentric origin with or without metastases."' 15 With the experimental study of leukemia and lymphosarcoma in guinea-pigs and mice, much progress has been made in-acquiring a more clear-cut understanding and classification." 12,' 13 14 On the basis of transplantation experiments, leukemia in these animals has definitely been demonstrated to be a neoplastic disease.
The nature of the growths (lymphosarcomatous or leukemic) resulting from inoculation of different lines of neoplastic lymphocytes into uniform hosts is described in this paper. Variations in the behavior of different neoplastic lymphocytes in the same environment might afford a basis for differentiation between lymphosarcoma and leukemia.
Materials and methods
The experimental animals used were inbred mice of several strains-A, F, C3H, CBA, C57. All of these strains have been maintained by brother-sister matings for many generations. In transplantation experiments young mice were used to exclude spontaneous leukemia.
Three lines of malignant lymphoid disease were established in the A strain, 2 in the CBA, 3 in the C3H, 1 in the C57, and 4 lymphoid and 3 myeloid in the F strain7 (Table 1 ). In addition, the Mal Fil 6 sarcoma of Liver, spleen, lymph nodes, kidneys, thoracic viscera, and tumors were fixed in Zenker-formol, imbedded in paraffin, sectioned, and stained with hematoxylin-eosin or eosin-orange G-toluidin-blue (Dominici). Touch preparations of lymph nodes, liver, spleen, and bone-marrow were made. These and the blood smears were stained by the May-Griunwald-Giemsa technic. 5' 6 Only one of the 16 lines of malignant lymphoid or myeloid disease studied never produced systemic lesions upon subcutaneous or intraperitoneal inoculation of viable cells. This line has been designated line G. The original lymphosarcoma arose in the mediastinum of a mouse injected with 14,250 i.u. of hydroxy-estrin benzoate over a period of 206 days. In order to determine whether this line would produce systemic disease when its cells were inoculated intravenously, the following experiment, as summarized in Table 2 (Table 2) were inoculated into A-strain mice the end-result was the same, regardless of the route of inoculation (Fig. 2) . All lymph nodes were filled with leukemic cells, the blood was leukemic, spleens were enlarged, periportal areas in the liver were infiltrated, lungs were leukemic, bone-marrow was replaced by leukemic lymphocytes, and perivascular and intertubular accumulations of lymphocytes appeared in the kidneys. The latent period was approximately the same following either subcutaneous, intraperitoneal, or intravenous inoculation (Table 2 ).
In the 6th transfer generation of line A, before the line gave uniform results, one mouse developed a large subcutaneous tumor with apparently no distant metastases. An attempt was made to establish a sarcomatous sub-line. Although hosts of the next transfer generation developed rather large local tumors at the implantation site, systemic leukemia also appeared.
Discussion
The concept of the neoplastic nature of mouse leukemia is reaffirmed by these experiments. In 12 transfer lines of frank leukemia subcutaneous tumors appeared when leukemic cells were inoculated under the skin. These local tumors were composed of leukemic cells, either lymphoid or myeloid. In all cases where the original donor showed generalized leukemic lesions the cells of the lines established from these cases produced leukemia as well as subcutaneous tumors following subcutaneous inoculation. Apparently, the local tumors usually developed first and malignant lymphocytes metastasized from the local tumor to lymph nodes, bone-marrow, and thoracic and abdominal organs. In line G, which was established from a spontaneous case of mediastinal lymphosarcoma without systemic disease, cells failed to spread by way of the blood and lymph stream from either subcutaneous or intraperitoneal tumors developing in hosts receiving inoculations of cells at these sites. Since fewer takes resulted and the latent period was prolonged when the cells were inoculated intravenously, it appears that the intravascular environment was less favorable than the extravascular loci for the life of these cells. In working with mice resistant to transplantable leukemia, Furth, Seibold, and Rathbone3 found that, in general, more takes were recorded if the intravenous rather than the subcutaneous route of inoculation was used. In line G, however, fewer takes were obtained with intravenous than subcutaneous inoculation. It would seem that in most cases where intravenous inoculations resulted in takes cells had probably left the circulation and had formed lymphosarcomata at the point of escape. Although in a few instances the distribution of lesions simulated that found in leukemia, this does not necessarily mean that these cells are potentially leukemic, since the Mal Fil 6 sarcoma, a non-lymphoid mesenchymal tumor, behaved in a similar manner. Infiltrations of liver and spleen by line G lymphocytes may have been by direct extension from large abdominal tumors, since some tumors growing in the axilla invaded the thoracic cavity by direct extension, the lungs then containing peribronchial and perivascular accumulations of lymphocytes. Local tumors composed of leukemic cells (Fig. 2) were similar microscopically to line G lymphosarcomata (Fig. 3) . Metastatic behavior rather than histological characteristics differentiate the sarcomatous from the leukemic lymphocytes.
Additional observations have shown that the incidence of lymphoid neoplastic disease is increased in mice receiving high doses of estrogen.4 Many of the animals develop tumors in the mediastinum without metastases from this region. Upon transplantation into normal mice some of these tumors have produced systemic leukemia. Although the spontaneous cases died with only local infiltrative growths it might be assumed that the position of the tumor was responsible for the death of the animal before metastatic lesions appeared. In line G, however, the cells were really "lymphosarcomatous" and not "leukemic." More mediastinal tumors of spontaneous cases are being transplanted to determine what proportion is capable of invading the blood stream.
The observations of Furth, Ferris, and Reznikoff' that the cells which produce large tumors invade the blood with difficulty have been confirmed. Apparently, gradations exist between lymphoid neoplasms which do not invade the blood from an extravascular site of growth (line G), those which invade the blood to only a slight degree (lines S and C57), those which form massive local tumors but always invade the blood (line C), and those which invade the blood and spread so readily by this route that the animals die before local tumors have become very large (line A). These findings are in general agreement with those of the above authors.' The cells and not the hosts were apparently responsible for the different types of growth noted in these observations. Furth, Ferris, and Reznikoff' and Potter and MacDowell8 have shown, however, that alterations in the hosts (irradiation with x-ray or partial immunization) will modify the type of growth given by cell lines which have become uniform for normal, susceptible hosts.
The excellent investigations of Potter, Victor, and Ward10 with the C58 strain, whereby excision of single enlarged lymph nodes suggested a delay in the appearance of spontaneous leukemia for many months, presumably until another leukemic focus arose, indicate the unicentric origin of even systemic leukemia. Excised nodes in their experiments produced leukemia when inoculated into normal mice.* Leukemia may follow the inoculation of a single cell. 
